MethodsIn an effort to help characterize the LD landscape, we estimated the number of PTLD cases in the US in 2016 and 2020 using Monte-Carlo simulation techniques, publically-available demographic datasets, uncertainty in the inputs and realistic assumptions about
incidence and treatment failure rates.
ResultsDepending on the input assumptions, PTLD prevalence estimates for 2016 ranged from 69,011 persons (95% CI 51,796 to 89,312) to 1,523,869 (CI 1,268,634 to 1,809,416). Prevalence in 2020 is predicted to be higher than 2016,
and may be as high as 1,944,189 (CI 1,619,988 to 2,304,147) cases.ConclusionsThe cumulative prevalence of PLTD in the United States is estimated to be high and continues to increase. These findings will be of interest to epidemiologists and health economists studying disease burden in the US and elsewhere, and justify funding to study PTLD diagnosis and treatment.
Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020
Allison DeLong, Mayla Hsu and Harriet Kotsoris
BMC Public Health 2019 19:352
https://doi.org/10.1186/s12889-019-6681-9 © The Author(s). 2019
Received: 27 July 2018 Accepted: 19 March 2019 Published:
24 April 2019Press:
https://bit.ly/2gnd6iohttps://bit.ly/2xprevu